Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Valeria Catalani"'
Publikováno v:
Emerging Trends in Drugs, Addictions, and Health, Vol 4, Iss , Pp 100143- (2024)
In 2019, we published three innovative quantitative structure-activity relationship models (QSAR) for predicting the affinity of mu-opioid receptor (µOR) ligands. The three different models were then combined to produce a consensus model used to exp
Externí odkaz:
https://doaj.org/article/95124a7dfdfd42bb85491eb646faa509
Autor:
Giuseppe Floresta, Davide Arillotta, Valeria Catalani, Gabriele Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Fabrizio Schifano
Publikováno v:
Scientia Pharmaceutica, Vol 92, Iss 2, p 17 (2024)
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained considerable attention as a therapeutic agent for type 2 diabetes mellitus and obesity. Despite its clinical success, the precise mechanisms underlying its pharmacological ef
Externí odkaz:
https://doaj.org/article/39e4a583a06c4abb906eb1586e0d3cac
Autor:
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John M. Corkery, Jacqueline L. Stair, Fabrizio Schifano, Amira Guirguis
Publikováno v:
Pharmacy, Vol 12, Iss 1, p 13 (2024)
Introduction: The designer benzodiazepine (DBZD) market continues to expand whilst evading regulatory controls. The widespread adoption of social media by pro-drug use communities encourages positive discussions around DBZD use/misuse, driving demand
Externí odkaz:
https://doaj.org/article/5aeb7dcbe1cf4cb690ea2e3802b0b0b7
Autor:
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano
Publikováno v:
Brain Sciences, Vol 13, Iss 11, p 1503 (2023)
The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes. Social media platforms’ users started promoting sema
Externí odkaz:
https://doaj.org/article/69f1dc09eced42b0b8b072dfd0ed999f
Autor:
Valeria Catalani, Honor D Townshend, Mariya Prilutskaya, Robert P Chilcott, Antonio Metastasio, Hani Banayoti, Tim McSweeney, Ornella Corazza
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287231 (2023)
AimsThe COVID-19 pandemic triggered a demand for vaccines, cures, and the need of related documentation for travel, work and other purposes. Our project aimed to identify the illicit availability of such products across the Dark Web Markets (DWMs).Me
Externí odkaz:
https://doaj.org/article/3c33af75ee6a498c8cedd9ac9cbc082a
Autor:
Valeria Catalani, Honor D. Townshend, Mariya Prilutskaya, Andres Roman-Urrestarazu, Robin van Kessel, Robert P. Chilcott, Hani Banayoti, Tim McSweeney, Ornella Corazza
Publikováno v:
Emerging Trends in Drugs, Addictions, and Health, Vol 3, Iss , Pp 100051- (2023)
Background: In a time of unprecedented global change, the COVID-19 pandemic has led to a surge in demand of COVID-19 vaccines and related certifications. Mainly due to supply shortages, counterfeit vaccines, fake documentation, and alleged cures to i
Externí odkaz:
https://doaj.org/article/1a96c812473f42be99fb9cd1575906c0
Autor:
Valeria Catalani, Davide Arillotta, John Martin Corkery, Amira Guirguis, Alessandro Vento, Fabrizio Schifano
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2021)
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aim
Externí odkaz:
https://doaj.org/article/b7344babb3864c07b8e6ce11d739912a
Autor:
Valeria Catalani, Attilio Negri, Honor Townshend, Pierluigi Simonato, Mariya Prilutskaya, Anna Tippett, Ornella Corazza
Publikováno v:
Emerging Trends in Drugs, Addictions, and Health, Vol 1, Iss , Pp 100014- (2021)
Background: The market of sport supplements is expanding worldwide. Such phenomenon is often supported by captivating marketing strategies and social media advertising providing unscientifically founded claims, thus raising safety concerns. The aim o
Externí odkaz:
https://doaj.org/article/00211ec964ae456986b5af7c8d1eee0d
Autor:
Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano
Publikováno v:
Pharmaceuticals, Vol 14, Iss 8, p 720 (2021)
Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics. Here, comput
Externí odkaz:
https://doaj.org/article/da84506a87594bb5beedf469652367e7
Autor:
Valeria Catalani, Mariya Prilutskaya, Ahmed Al-Imam, Shanna Marrinan, Yasmine Elgharably, Mire Zloh, Giovanni Martinotti, Robert Chilcott, Ornella Corazza
Publikováno v:
Brain Sciences, Vol 8, Iss 2, p 34 (2018)
Background: Octodrine is the trade name for Dimethylhexylamine (DMHA), a central nervous stimulant that increases the uptake of dopamine and noradrenaline. Originally developed as a nasal decongestant in the 1950’s, it has recently been re-introduc
Externí odkaz:
https://doaj.org/article/c1e669b135c94986ba7606a937f0a735